The relationship between sleep and opioids in chronic pain patients
- 20 February 2021
- journal article
- research article
- Published by Springer Nature in Journal of Behavioral Medicine
- Vol. 44 (3) , 412-420
Abstract
Background. Sleep problems are common among chronic pain patients who take opioids. There are documented effects of opioids on sleep architecture; however, the long-term effects of opioids on sleep remain unknown. This study examined whether opioid-naïve participants have better sleep quality than current and previous chronic users of opioids. We also explored whether sleep differed between methadone and buprenorphine users, and whether amount of time since abstaining from opioids was associated with sleep quality. Method. Participants were 120 people with chronic pain (84.2% Caucasian, Mage = 42.0 years, SD = 11.44). They were in one of four groups of 30 participants each: (1) current users of methadone for opioid use disorder (OUD); (2) current users of buprenorphine for OUD; (3) a history of medication-assisted therapy for OUD but currently opioid-abstinent for at least 6 months; (4) those who have less than one month of cumulative lifetime opioids (opioid-naïve group). Only participants in group 1 and group 2 were taking opioids during the time of the study. Participants completed the Pittsburgh Sleep Quality Index and the SF-36. Results. A MANCOVA revealed that all three groups with current or previous opioid use (i.e., groups 1–3) differed significantly from the opioid-naïve group (group 4) on sleep quality, sleep duration, sleep disturbances, and daytime dysfunction after controlling for sleep medications (all p < .05). For group 1 (methadone users), 2 (buprenorphine users), and 3 (prolonged abstinence), there were no statistically significant differences between each group. There was also a significant relationship between opioid-abstinent weeks and sleep disturbances in the opioid-abstinent group (r = − 0.604, p < .001). Discussion. The results of this study suggest that opioids interfere with sleep quality, even after months of abstention. Further research into the long-term effects of opioids is warranted and may contribute further to the importance of addressing sleep problems in this population.Keywords
Funding Information
- National Institute on Drug Abuse (K23 #DA030397, R34 #DA041549)
This publication has 37 references indexed in Scilit:
- Craving of Prescription Opioids in Patients With Chronic Pain: A Longitudinal Outcomes TrialThe Journal of Pain, 2012
- Buprenorphine Disrupts Sleep and Decreases Adenosine Concentrations in Sleep-regulating Brain Regions of Sprague Dawley RatAnesthesiology, 2011
- Assessing sleep in opioid dependence: A comparison of subjective ratings, sleep diaries, and home polysomnography in methadone maintenance patientsDrug and Alcohol Dependence, 2011
- Opioid-induced Decreases in Rat Brain Adenosine Levels Are Reversed by Inhibiting Adenosine DeaminaseAnesthesiology, 2009
- Beyond Baron and Kenny: Statistical Mediation Analysis in the New MillenniumCommunication Monographs, 2009
- Documented poor sleep among methadone-maintained patients is associated with chronic pain and benzodiazepine abuse, but not with methadone doseEuropean Neuropsychopharmacology, 2009
- Health status of clients receiving methadone maintenance treatment using the SF‐36 health survey questionnaireDrug and Alcohol Review, 2004
- Sleeping with the hypothalamus: emerging therapeutic targets for sleep disordersNature Neuroscience, 2002
- Validating the SF-36 health survey questionnaire: new outcome measure for primary care.BMJ, 1992
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992